Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

American Heart Journal

Topics

Engineering

Epidemiology

Medicine

Immunology

Pathology

Show all topics

DOI

10.1016/j.ahj.2011.06.012